Xenotransplantation is any procedure that involves the transplantation, implantation or infusion into a human recipient of either (a) live cells, tissues, or organs from a nonhuman animal source, or (b) human body fluids, cells, tissues or organs that have had ex vivo contact with live nonhuman animal cells, tissues or .
Tissues or organs that can be used for xenotransplantation (Ekser et al. 2012).
One approach is to genetically modify the donor pigs to reduce or prevent attack by the human immune system, and thus achieve the compatibility with the human body..
Xenotransplantation is the attempt to use living biological material from nonhuman animal species in humans for therapeutic purposes.
Clinical trials and preclinical studies have suggested that living cells and tissue from other species have the potential to be used in humans to ameliorate disease..
Xenotransplantation products include those from transgenic or nontransgenic nonhuman animals and composite products that contain xenotransplantation products in combination with drugs or devices.
Some examples are: Porcine fetal neuronal cells.
Encapsulated porcine islet cells..
However, several countries, including Russia, China, and some Eastern European nations, have forged ahead.
According to anecdotal reports, hundreds of xenotransplants have been performed in these countries for the treatment of diabetes, using pancreatic tissue from pigs, cows, and rabbits..
Synthetic biology helps to address the critical lack of organs through both tissue-engineering strategies in vitro and in vivo to create organs and the use of complex genome engineering to address the host rejection mechanisms..
Xenotransplantation, or the transplantation of living tissues or organs from one species to another, alleviates the shortage of human organs such as heart and kidney.
Pigs have a similar physiology and organ size, making porcine (pig) organs ideal candidates for transplantation into human recipients..
Xenotransplantation is the attempt to use living biological material from nonhuman animal species in humans for therapeutic purposes.
Clinical trials and preclinical studies have suggested that living cells and tissue from other species have the potential to be used in humans to ameliorate disease..
However, the increase in transplant candidates in this decade, and the ensuing quantitative crunch from an outstripped supply, has ultimately led to a resurgence of interest in xenotransplants as a source of organs, especially for children. Current interest in xenotransplantation is fueled by promising results and significant demand.
In the context of xenotransplantation, the assault by antibodies and complement-activated pig endothelial cells converts endothelial cells from an anticoagulant phenotype to a procoagulant state, leading to vascular destruction, and infiltration by various immune cells ( 87 ).
Keywords:
Xenotransplantation research marked a singular milestone last year with the first human transplants of kidneys and a heart from genetically engineered pigs.
The genetic modifications were designed to improve transplantation outcomes by lessening immune rejection, controlling organ size and regulating complement, coagulation and inflammation.
